Annovis Bio (ANVS) Stock Chart & Stock Price History $8.50 -0.14 (-1.62%) (As of 09/20/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Annovis Bio Stock Price Performance5 Day Performance+6.12%1 Month Performance-4.60%3 Month Performance+41.20%6 Month Performance-23.32%Year-To-Date Performance-54.55%1 Year Performance-20.63% Receive ANVS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Annovis Bio and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the Markets“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Take these 4 steps to protect your retirement here >>> ANVS Stock Chart for Friday, September, 20, 2024 ANVS Chart by TradingView Annovis Bio Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/19/2024$8.36$8.68+3.83%$8.99$8.35136,964 shs$96.96 million09/18/2024$8.74$8.36-4.35%$9.00$8.35227,758 shs$93.39 million09/17/2024$8.02$8.74+8.98%$9.50$8.00361,418 shs$97.64 million09/16/2024$8.01$8.02+0.12%$8.35$7.9475,340 shs$89.59 million09/13/2024$8.47$8.01-5.43%$8.60$7.94158,759 shs$104.53 million09/12/2024$8.55$8.47-0.94%$8.73$8.3093,766 shs$94.62 million Get the Latest News and Ratings for ANVS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Annovis Bio and its competitors with MarketBeat's FREE daily newsletter. 09/11/2024$8.36$8.55+2.27%$8.68$8.13186,507 shs$95.51 million09/10/2024$8.18$8.36+2.20%$8.44$8.1399,572 shs$109.10 million09/09/2024$7.87$8.18+3.94%$8.40$7.81104,628 shs$106.75 million09/06/2024$7.86$7.87+0.13%$7.92$7.45129,667 shs$87.92 million09/05/2024$8.43$7.86-6.76%$8.55$7.71244,931 shs$87.80 million09/04/2024$8.35$8.43+0.96%$8.57$8.19139,454 shs$94.17 million09/03/2024$8.46$8.35-1.30%$8.70$8.14116,403 shs$93.28 million09/02/2024$8.46$8.46$8.82$8.26110,000 shs$94.51 million08/30/2024$8.83$8.48-3.96%$8.82$8.26109,519 shs$94.73 million08/29/2024$8.75$8.83+0.91%$9.09$8.63124,093 shs$98.64 million08/28/2024$9.13$8.75-4.16%$9.15$8.62209,120 shs$97.75 million08/27/2024$9.65$9.13-5.39%$9.82$9.11149,986 shs$101.99 million08/26/2024$9.69$9.65-0.41%$9.95$9.45125,021 shs$107.80 million08/23/2024$9.15$9.67+5.68%$9.98$9.25350,909 shs$108.02 million08/22/2024$9.61$9.15-4.79%$9.93$9.01191,154 shs$102.22 million08/21/2024$8.91$9.61+7.86%$9.80$8.90340,568 shs$107.35 million08/20/2024$8.93$8.91-0.22%$9.21$8.6595,938 shs$99.53 million08/19/2024$8.53$8.93+4.69%$9.05$8.41242,322 shs$99.76 million08/16/2024$8.86$8.51-3.95%$9.10$8.43268,836 shs$95.07 million08/15/2024$7.75$8.86+14.32%$9.58$8.05661,874 shs$98.98 million08/14/2024$7.97$7.75-2.76%$8.07$7.72204,027 shs$86.58 million08/13/2024$7.87$7.97+1.27%$8.19$7.87155,319 shs$89.03 million08/12/2024$7.69$7.87+2.34%$7.91$7.58115,134 shs$87.92 million08/09/2024$8.25$7.70-6.67%$8.43$7.58323,906 shs$86.02 million08/08/2024$8.02$8.25+2.87%$8.50$7.83198,285 shs$92.16 million08/07/2024$8.36$8.02-4.07%$8.50$7.82224,768 shs$89.59 million08/06/2024$8.41$8.36-0.59%$8.82$8.36263,333 shs$93.39 million08/05/2024$8.66$8.41-2.89%$8.57$7.70256,571 shs$93.95 million08/02/2024$9.13$8.64-5.32%$8.91$8.41247,690 shs$96.51 million08/01/2024$9.33$9.13-2.20%$9.85$8.89371,312 shs$101.93 million07/31/2024$9.50$9.33-1.79%$9.82$8.76437,756 shs$104.22 million07/30/2024$10.61$9.50-10.46%$10.63$9.41451,307 shs$106.12 million07/29/2024$10.96$10.61-3.19%$11.29$10.45226,604 shs$118.51 million07/26/2024$10.45$10.96+4.93%$11.20$10.18369,730 shs$122.43 million“Buffett Indicator” Predicts 62% Stock Market Crash (Ad)The last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Take these 4 steps to protect your retirement here >>>07/25/2024$10.77$10.45-3.02%$10.84$10.20194,042 shs$116.67 million07/24/2024$10.64$10.77+1.22%$11.69$10.50407,816 shs$120.30 million07/23/2024$10.76$10.64-1.12%$11.11$10.50284,414 shs$118.85 million07/22/2024$11.33$10.76-5.03%$11.54$10.32405,596 shs$120.19 million07/19/2024$11.39$11.26-1.14%$11.54$10.52444,142 shs$125.77 million07/18/2024$12.46$11.39-8.59%$12.57$11.15531,105 shs$127.23 million07/17/2024$12.45$12.46+0.08%$13.38$11.77469,730 shs$139.18 million07/16/2024$12.60$12.45-1.19%$13.91$12.44959,712 shs$139.08 million07/15/2024$12.16$12.60+3.62%$13.00$12.03505,337 shs$140.74 million07/12/2024$13.18$12.24-7.13%$13.53$12.04982,236 shs$136.72 million07/11/2024$12.14$13.18+8.57%$14.79$12.422.58 million shs$147.22 million07/10/2024$14.57$12.14-16.68%$14.14$11.422.11 million shs$135.60 million07/09/2024$15.42$14.57-5.51%$17.88$13.753.93 million shs$162.75 million07/08/2024$11.10$15.42+38.92%$17.32$11.0822.13 million shs$172.24 million07/05/2024$8.08$11.00+36.14%$11.46$7.6916.17 million shs$122.87 million07/04/2024$8.08$8.08$9.24$7.385.39 million shs$90.25 million07/03/2024$9.22$8.08-12.32%$9.24$7.385.38 million shs$90.25 million07/02/2024$5.27$9.22+74.86%$12.51$4.5340.54 million shs$102.93 million07/01/2024$5.76$5.27-8.51%$5.99$5.27357,774 shs$58.87 million06/28/2024$6.02$5.71-5.23%$6.14$5.56143,776 shs$63.73 million06/27/2024$5.73$6.02+5.06%$6.18$5.66163,059 shs$67.24 million06/26/2024$5.58$5.73+2.69%$5.95$5.71140,256 shs$64.00 million06/25/2024$6.14$5.58-9.12%$5.97$5.55208,016 shs$62.33 million06/24/2024$5.94$6.14+3.37%$6.30$5.73193,748 shs$68.58 million06/21/2024$6.02$5.94-1.33%$6.24$5.60241,876 shs$66.35 million06/20/2024$5.31$6.02+13.37%$6.02$5.22185,048 shs$67.24 million06/19/2024$5.31$5.31$5.85$5.31223,458 shs$59.31 million Related Companies: Organogenesis Stock Chart Galecto Stock Chart Neoleukin Therapeutics Stock Chart G1 Therapeutics Stock Chart biote Stock Chart Alto Neuroscience Stock Chart Inozyme Pharma Stock Chart Lyell Immunopharma Stock Chart Korro Bio Stock Chart Jasper Therapeutics Stock Chart Receive ANVS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Annovis Bio and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:ANVS) was last updated on 9/20/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredTrump’s “Tax Free” Retirement StrategySince 1924 — over one hundred years — the US dollar has lost nearly 18x its value. If you're planning on re...Gold Safe Exchange | SponsoredThe election trade you can't losePolitics is an unpredictable game. But no matter what happens in the next few months... There's one thin...Investors Alley | SponsoredAre You Ready for a Small-Cap Rally?Jeff Bezos has just made a bold move into Quantum Computing as a Service (QaaS), a technology set to disrupt i...InvestorPlace | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredMust-Know for Trading OptionsOptions are becoming increasingly popular among investors – with demand hitting record highs for 3 years in a ...Unstoppable Prosperity | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Annovis Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Annovis Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.